EyePoint

14.55
Open
13.62
Market Cap
1.21B+
High
14.88
Low
13.61
Close
14.38
Volume
1.55M+
P/E Ratio
-4.55
Div/Yield
0.00%

About EyePoint

EyePoint Pharmaceuticals Inc. was incorporated in Delaware in March 2008. Its predecessor, pSivida Limited, was originally registered as an Australian company in Western Australia in December 2000. pSivida specialized in developing tiny, sustained-release drug delivery systems designed to provide controlled and steady medication release over months or even years. The company focused on leveraging its core technology platforms, Durasert and BioSilicon, to treat chronic diseases affecting the back of the eye. Currently, pSivida has three approved products and two major candidates in development, representing successive generations of the Durasert technology platform. Notably, three-quarters of the sustained-release devices developed by pSivida target retinal diseases and have received regulatory approval in either the United States or the European Union. For more information, visit their website at http://www.eyepointpharma.com. The company is located at 480 Pleasant Street, Watertown, MA 02472.

How to Buy EyePoint (EYPT)

Sign In
1-Minute Account Opening

1-Minute Account Opening

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Deposit funds

Deposit funds

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Buy EYPT

Buy EYPT

Search for EYPT via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.